...
首页> 外文期刊>International Journal of Pharmaceutics >Defined drug release from 3D-printed composite tablets consisting of drugloaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler
【24h】

Defined drug release from 3D-printed composite tablets consisting of drugloaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler

机译:由3D印刷复合片剂中定义的药物释放,由药物载荷的聚乙烯醇和水溶性或水不溶性聚合物填料组成

获取原文
获取原文并翻译 | 示例
           

摘要

3D-printed tablets are a promising new approach for personalized medicine. In this study, we fabricated composite tablets consisting of two components, a drug and a filler, by using a fused deposition modeling-type 3D printer. Polyvinylalcohol (PVA) polymer containing calcein (a model drug) was used as the drug component and PVA or polylactic acid (PLA) polymer without drug was used as the water-soluble or water-insoluble filler, respectively. Various kinds of drug-PVA/PVA and drug-PVA/PLA composite tablets were designed, and the 3Dprinted tablets exhibited good formability. The surface area of the exposed drug component is highly correlated with the initial drug release rate. Composite tablets with an exposed top and a bottom covered with a PLA layer were fabricated. These tablets showed zero-order drug release by maintaining the surface area of the exposed drug component during drug dissolution. In contrast, the drug release profile varied for tablets whose exposed surface area changed. Composite tablets with different drug release lag times were prepared by changing the thickness of the PVA filler coating the drug component. These results which used PVA and PLA filler will provide useful information for preparing the tablets with multi-components and tailor-made tablets with defined drug release profiles using 3D printers.
机译:3D印花平板电脑是个性化医学的一种很有的新方法。在本研究中,我们通过使用熔融沉积建模型3D打印机制造由两种组分,药物和填料组成的复合片剂。使用含有Calcein(模型药物)的聚乙烯醇(PVA)聚合物作为药物成分,PVA或聚乳酸(PLA)聚合物,分别用作水溶性或水不溶性填料。设计了各种药物-PVA / PVA和药物PVA / PLA复合片,3DPrinted片剂表现出良好的成形性。暴露的药物组分的表面积与初始药物释放速率高度相关。制造具有暴露顶部的复合片剂和底部覆盖着PLA层的底部。这些片剂通过在药物溶解期间维持暴露的药物组分的表面积显示零阶药物释放。相反,药物释放曲线变化,其暴露表面区域改变的片剂。通过改变药物组分的PVA填充物的厚度来制备具有不同药物释放滞后时间的复合片剂。使用PVA和PLA填料的这些结果将提供用于制备具有多组分的片剂和使用3D打印机具有定义的药物释放曲线的片剂的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号